Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

45.01
Delayed Data
As of Oct 20
 -1.79 / -3.82%
Today’s Change
13.09
Today|||52-Week Range
52.35
+202.08%
Year-to-Date

Today’s Trading

Previous close46.80
Today’s open47.34
Day’s range44.56 - 48.31
Volume84,626
Average volume (3 months)70,227
Market cap$562.4M
Dividend yield--
Data as of 4:00pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+46.22%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratio2.3
Price/Sales--
Price/Book14.77

Competitors

 Today’s
change
Today’s
% change
MNKDMannKind Corp+0.15+3.79%
ZYMEZymeworks Inc0.000.00%
ALBOAlbireo Pharma Inc+0.65+2.36%
OBSVObseva SA+0.27+2.57%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 14, 2017
EPS forecast (this quarter)-$0.76
Annual revenue (last year)$0.00
Annual profit (last year)-$26.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Paul A. Friedman
Chief Financial Officer &
Senior Vice President
Marc R. Schneebaum
Corporate headquarters
Fort Washington, Pennsylvania

Forecasts